CANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 filejanuary 22nd, 2016 cancercoreeurope conference on...

1
JANUARY 22 nd , 2016 C ANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 HEIDELBERG - GERMANY GERMAN CANCER RESEARCH CENTER (DKFZ), Lecture Hall 08:30 Registration 09:30 Welcome Fabien Calvo, Anthony Ho, Christof von Kalle und Thorsten Zenz Session I: Indolent Lymphoma Chairs: Hedda Wardemann / Vincent Ribrag 09:45 Molecular Basis of Indolent Lymphoma Ingo Ringshausen, Cambridge 10:10 Standard of Care 2016 Martin Dreyling, München 10:35 Future Directions Improving Outcome in Indolent Lymphoma Vincent Ribrag, Paris 11:00 Clinical Implications of Gene Mutations in Follicular Lymphoma (Abstract) Oliver Weigert, München 11:15 Coffee Break Session II: CLL Chairs: Francesc Bosch / Anders Österborg 11:30 Molecular Basis of CLL Olivier Bernard, Paris 11:55 Standard of Care 2016 Francesc Bosch, Barcelona 12:20 Future Directions Improving Outcome in CLL Anders Österborg, Stockholm 13:00 Lunch Session III: Aggressive B-NHL Chairs: George Follows / Thorsten Zenz 14:00 Molecular Basis of Aggressive B-NHL Clemens Schmitt, Berlin 14:25 Standard of Care 2016 Christian Gisselbrecht, Paris 14:50 Future Directions Improving Outcome in Aggressive B-NHL Georg Lenz, Münster 15:15 FOXO1 Impacts on Germinal Center Derived Lymphomagenesis (Abstract) Sandrine Sander, Heidelberg Session IV: T-NHL Chairs: Hans-Reimer Rodewald / Mathias Witzens-Harig 15:45 Molecular Basis of T-NHL Laurence de Leval, Lausanne 16:10 Standard of Care 2016 Lorenz Trümper, Göttingen 16:35 Future Directions Improving Outcome in T-NHL Pier Luigi Zinzani, Bologna 17:00 The Pan-PIM Kinase Inhibitor LGB321 Targets Apoptotic Pathways and Microenvironmental Interactions in CLL (Abstract) Christine Dierks, Freiburg 17:15 Coffee Break 17:45 Satellite Symposium Chairs: Susan O’Brien / Christian Peschel 17:45 Improving Chemotherapy in NHL Kieron Dunleavy, Bethesda 18:10 BCR Inhibition in B-Cell Lymphoma/CLL Susan O’Brien, Irvine 18:35 Strategies for Cure in CLL Michael Hallek, Cologne 19:00 Drug Sensitivity-Based Functional Taxonomy of Lymphoma Thorsten Zenz, Heidelberg 20:00 Get-Together Registration: Fortbildungs- und Veranstaltungsorganisation des Nationalen Centrums für Tumorerkrankungen (NCT) Heidelberg School of Oncology Im Neuenheimer Feld 460 69120 Heidelberg Phone +49 (0) 6221 56-6558 viktoria.reinhardt@ nct-heidelberg.de www.nct-heidelberg.de/ lymphoma2016 For this event, six points for continuing education will be given by the „Landesärztekammer“ WITH FRIENDLY SUPPORT OF (PROMOTION AND PRESENTATION): (1.000,00€) (5.000,00€) Erste Wahl für das zweite Leben (5.000,00€) (10.000,00€) (10.000,00€) (10.000,00€) (3.000,00€) (3.000,00€) ONCOLOGY (3.000,00€)

Transcript of CANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 filejanuary 22nd, 2016 cancercoreeurope conference on...

Page 1: CANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 filejanuary 22nd, 2016 cancercoreeurope conference on lymphoma 2016 heidelberg - germany german cancer research center (dkfz), lecture

JANUARY 22nd, 2016

CANCERCOREEUROPE CONFERENCE ON

LYMPHOMA 2016HEIDELBERG - GERMANYGERMAN CANCER RESEARCH CENTER (DKFZ), Lecture Hall

08:30 Registration

09:30 Welcome Fabien Calvo, Anthony Ho, Christof von Kalle und Thorsten Zenz

Session I: Indolent Lymphoma Chairs: Hedda Wardemann / Vincent Ribrag

09:45 Molecular Basis of Indolent Lymphoma Ingo Ringshausen, Cambridge

10:10 Standard of Care 2016 Martin Dreyling, München

10:35 Future Directions Improving Outcome in Indolent Lymphoma Vincent Ribrag, Paris

11:00 Clinical Implications of Gene Mutations in Follicular Lymphoma (Abstract) Oliver Weigert, München

11:15 Coffee Break

Session II: CLL Chairs: Francesc Bosch / Anders Österborg

11:30 Molecular Basis of CLL Olivier Bernard, Paris

11:55 Standard of Care 2016 Francesc Bosch, Barcelona

12:20 Future Directions Improving Outcome in CLL Anders Österborg, Stockholm

13:00 Lunch

Session III: Aggressive B-NHL Chairs: George Follows / Thorsten Zenz

14:00 Molecular Basis of Aggressive B-NHL Clemens Schmitt, Berlin

14:25 Standard of Care 2016 Christian Gisselbrecht, Paris

14:50 Future Directions Improving Outcome in Aggressive B-NHL Georg Lenz, Münster

15:15 FOXO1 Impacts on Germinal Center Derived Lymphomagenesis (Abstract) Sandrine Sander, Heidelberg

Session IV: T-NHL Chairs: Hans-Reimer Rodewald / Mathias Witzens-Harig

15:45 Molecular Basis of T-NHL Laurence de Leval, Lausanne

16:10 Standard of Care 2016 Lorenz Trümper, Göttingen

16:35 Future Directions Improving Outcome in T-NHL Pier Luigi Zinzani, Bologna

17:00 The Pan-PIM Kinase Inhibitor LGB321 Targets Apoptotic Pathways and Microenvironmental Interactions in CLL (Abstract) Christine Dierks, Freiburg

17:15 Coffee Break

17:45 Satellite Symposium Chairs: Susan O’Brien / Christian Peschel

17:45 Improving Chemotherapy in NHL Kieron Dunleavy, Bethesda

18:10 BCR Inhibition in B-Cell Lymphoma/CLL Susan O’Brien, Irvine

18:35 Strategies for Cure in CLL Michael Hallek, Cologne

19:00 Drug Sensitivity-Based Functional Taxonomy of Lymphoma Thorsten Zenz, Heidelberg

20:00 Get-Together

Registration:

Fortbildungs- und Veranstaltungsorganisation des Nationalen Centrums für Tumorerkrankungen (NCT) Heidelberg School of Oncology

Im Neuenheimer Feld 460 69120 Heidelberg Phone +49 (0) 6221 56-6558 viktoria.reinhardt@ nct-heidelberg.de www.nct-heidelberg.de/ lymphoma2016

For this event, six points for continuing education will be given by the „Landesärzte kammer“

WITH FRIENDLY SUPPORT OF (PROMOTION AND PRESENTATION):

(1.000,00€)

(5.000,00€)Erste Wahl für das zwei te Leben

(5.000,00€)

(10.000,00€)

(10.000,00€)

(10.000,00€)

(3.000,00€)

(3.000,00€)

O N C O L O G Y

(3.000,00€)